
VIEW May consumer prices rise moderately
NEW YORK, June 10 (Reuters) - U.S. consumer prices rose slightly in May as gasoline prices remained subdued, but inflation is likely to pick up in the months as tariffs boost the cost of imported goods.
The consumer price index CPI increased 0.1% last month after rising 0.2% in April, the Labor Department said on Wednesday. Economists polled by Reuters had forecast the CPI would rise 0.2%. Year on year, the CPI climbed 2.4%, vs a 2.3% rise in the 12 months through April.
Excluding the volatile food and energy components, the CPI rose 0.1% after gaining 0.2% in April. The so-called "core" CPI inflation increased 2.8% on a year-on-year basis in May after rising 2.8% in April.
Inflation data has been slow to reflect U.S. President Donald Trump's slew of tariffs as retailers are selling merchandise that was built up before the levies took effect.
MARKET REACTION:
STOCKS: U.S. stock index futures erased earlier gains and were last up 18.5 points, or 0.31%, pointing to a modestly higher open on Wall Street
BONDS: The 10-year U.S. Treasury yield fell 3.4 basis points to 4.44% while the two-year yield declined 5.9 basis points to 3.954%
FOREX: The dollar index reversed modest gains and was off 0.26% to 98.71 while the euro was up 0.43% at $1.1472
COMMENTS: BRIAN JACOBSEN, CHIEF ECONOMIST, ANNEX WEALTH MANAGEMENT, MENOMONEE FALLS, WISCONSIN:
"The post from Trump about the trade deal with China threatened to suck the air out of the importance of this CPI number. A 55% tariff on China does not seem like a good deal for households and businesses in America, but it was slightly better than the 60% tariff platform he campaigned on.
"The CPI number was a lot tamer than expected. A lot of imported food items had relatively high inflation, like bananas rising 3.3% in price and toy prices rising 2.2%. Egg deflation is taking place with prices falling 2.7%. A little stability with trade policy could go a long way to help keep inflation from derailing. This is another example of why the Fed may shift its balance of risks to focusing more on growth threats than inflation threats."
SLAWOMIR SOROCZYNSKI, HEAD OF FIXED INCOME, CROWN AGENTS INVESTMENT MANAGEMENT, LONDON:
'The CPI printing lower has been a relief. Now we need to clear the 10-year and 30-year Treasury auctions this week and then the market can switch into holiday mode.'
GENNADIY GOLDBERG, HEAD OF US RATES STRATEGY, TD SECURITIES, NEW YORK
'The trade policy should still push inflation higher and that really feeds into the market reaction to this CPI print. I would say CPI came in notably better than expected for markets, with both headline and core surprising to the downside. Core goods were softer than expected, especially given weaker apparel prices. Core services were also relatively soft as well, with rents and OER coming in notably lower.
'All in all, this should drive a cautious bull steepening of the (Treasury) yield curve as investors pencil in more cuts. But there's still significant uncertainty around trade and investors know that that should push inflation higher in the months to come. It's a bit of stay of execution for the fixed income market for now.'
WASIF LATIF, PRESIDENT AND CHIEF INVESTMENT OFFICER, SARMAYA PARTNERS, PRINCETON, NEW JERSEY
'It came in lower than consensus expected. So it's giving a little bit of a relief rally to the market, between equities rallying and bond yields coming down. But that's the initial reaction but we would see how it comes through over the next few days, weeks and until next month's print.
"It's just one print and we have to take that into consideration and with a grain of salt and see how things pan out. There will continue to be impacts from things like tariffs and labor tightness because of immigration crackdown.
"The other component is the energy piece. It did contribute a little better than expected numbers, with energy being down. And now this past month, you're seeing energy to hold its own and continue to grind higher so that also needs to be taken in consideration.
"But net-net, it's a good number for this week and this month. It provides a little bit of relief. What's interesting is not only are you seeing equities jump here a little bit you're also seeing the US dollar decline because the markets is interpreting that it gives the Fed a little of a runway to reduce rates to the inflationary pressures that aren't there. The thing that is rallying the most on this news is gold.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Reuters
25 minutes ago
- Reuters
Home appliances swept up in expansion of Trump steel tariffs
June 12 (Reuters) - A range of imported household appliances including dishwashers, washing machines, refrigerators and more will be subject to President Donald Trump's expanded steel tariffs starting later this month, according to a notice posted on Thursday. The tariffs, which are currently at 50% for most countries, would take effect on an additional range of "steel derivative products" on June 23, the Commerce Department said in the notice. It is the second time since Trump initially ratcheted up tariffs on imported steel and aluminum, first to 25% starting in March and then to 50% this month, that his administration has expanded the list of derivative products affected by the import levies. Just before the first round of duties was set to take effect in March, they added nearly 300 product categories covering everything from horseshoes to bulldozer blades to the tariffs list. This time eight product lines were added: combined refrigerator-freezers; small and large dryers; washing machines; dishwashers; chest and upright freezers; cooking stoves, ranges and ovens; food waste disposals; and welded wire racks. "The tariff imposed ... will be assessed on these derivative products for the value of the steel content in each product," the Federal Register posting said.


The Independent
34 minutes ago
- The Independent
Trump's policies could have a major impact on your credit score. Here's how
Your support helps us to tell the story Read more Support Now From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging. At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story. The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it. Your support makes all the difference. Read more President Donald Trump returned to the White House this January with a flurry of sweeping orders – some of which may impact Americans' credit scores. Trump and his allies are set on enacting his 'One Big Beautiful Bill,' which would add trillions to the country's already sizable deficit and drive up interest rates, producing large-scale macroeconomic repercussions. Financial markets have already warned of the rising debt, with Moody's cutting its pristine 'Aaa' U.S. credit rating, which could take even further hits if the deficit continues to rise. To help pay for the bill, Republicans are looking to make cuts to Medicaid and food assistance programs, without which, more Americans are likely to go into medical debt. Some 15 million Americans with medical debt may suffer even greater consequences of Trump's policies after his administration paused a new Consumer Financial Protection Bureau rule that would ban the inclusion of medical debt on credit reports. As of now, medical debt can be included in credit scores and a significant amount of medical bills can drag down a credit score. A lower credit score means a person appears to be a bigger risk to a lender, such as a bank. That could lead to higher interest rates on loans, such as for a car or a home. open image in gallery President Donald Trump's spending bill will have far-reaching macroeconomic repercussions and likely impact Americans' credit scores. ( AP ) A Biden-era rule would have removed $49 million in medical debt from credit score records, but new leadership at CFPB appointed by Trump is attempting to reverse its course, NPR reported. In addition to the complete switch in its stance, the CFPB joined forces with plaintiffs who filed a lawsuit trying to stop the Biden ban. The rule has since been stuck in limbo, with Judge Sean Jordan from Texas' Eastern District federal court twice ordering a stay, delaying the rule's new start date until the end of July. The outcome of the lawsuit will have tremendous financial implications for millions of Americans whose medical debt has negatively impacted their credit scores. Meanwhile, consumer advocates have been speaking out on behalf of the medical debt rule, worried abandoning it would take away necessary consumer protections. "I'm disappointed for the 15 million Americans who have medical bills on their credit reports and have to suffer the consequences of poor credit scores because of it," Patricia Kelmar, senior director of health care campaigns at the U.S. PIRG Education Fund, told USA Today. open image in gallery Trump-appointed CFPB leaders is looking to reverse a Biden-era rule that would ban the inclusion of medical debt on credit reports. ( Copyright 2025 The Associated Press. All rights reserved. ) In the lawsuit filed in April, CFPB along with plaintiffs, the Consumer Data Industry Association and the Cornerstone Credit Union League, asked the judge to abandon the medical debt rule 'because it exceeds the bureau's statutory authority.' "We believe that Congress is the only one who can act on this and determine whether or not it can be on the credit report," Dan Smith, CEO and president of the Consumer Data Industry Association, told NPR. "Our intention here is to protect the credit reporting system. To ensure that it is as complete and accurate as possible," he said. In the lawsuit, the groups also note that the three largest credit bureaus - Experian, TransUnion and Equifax – no longer list paid medical debts, unpaid medical debts less than a year old and medical debts less than $500. Americans' credit scores may also see some changes thanks to a proposal from Trump that would cap credit card interest rates at 10 percent – a significant reduction from the current average interest rate of about 21 percent. Lower rates mean people would be able to pay back credit card bills quicker, and improve their credit scores by having less debt. The proposal was touted as a solution to the debt many Americans owe due to high credit card interest rates, Newsweek reported. open image in gallery Americans held $45 billion more in credit card debt in 2024 than in 2023. ( Getty Images/iStockphoto ) Americans held $1.21 trillion in credit card debt as of December 2024 – an increase of $45 billion from September 2024, per New York Fed data. Data also shows that 7.18 percent of U.S. credit card debt is in serious delinquency, likely causing many credit scores to take a serious downward spiral. Following Trump's campaign promise, Reps Alexandria Ocasio-Cortez (D-Ny) and Anna Paulina Luna (R-Fla) introduced legislation to cap credit card interest rates at a maximum of 10 percent. The measure would take the financial burden away from consumers, especially those with high-interest debt. The cap would last until January 1, 2031, according to the bill.


Reuters
34 minutes ago
- Reuters
US FDA puts on hold Rein Therapeutics' lung disease drug trial
June 12 (Reuters) - Rein Therapeutics (RNTX.O), opens new tab has paused patient enrollment and dosing in a mid-stage trial of its lung disease drug in the U.S. after the Food and Drug Administration placed a clinical hold, the drug developer said on Thursday. Shares of the company fell nearly 10% after the bell. The company was testing a drug named LTI-03 to treat patients with idiopathic pulmonary fibrosis (IPF). The disease causes scarring of the lungs that makes it harder for them to work properly. Rein said in a filing that it is actively working with the FDA to remove the clinical hold. The FDA and Rein did not immediately respond to Reuters' requests for comment on why the hold was placed. The drug was well-tolerated and safe in an early-stage study in patients with IPF, the company said in the filing. No drug-related serious adverse events have been reported in any studies treating patients with LTI-03, it added. Rein continues to study the drug and enroll patients in Australia and Europe.